BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lin L, Yu Q, Zheng J, Cai Z, Tian R. Fast quantitative urinary proteomic profiling workflow for biomarker discovery in kidney cancer. Clin Proteomics 2018;15:42. [PMID: 30607141 DOI: 10.1186/s12014-018-9220-2] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Lin L, Zheng J, Zheng F, Cai Z, Yu Q. Advancing serum peptidomic profiling by data-independent acquisition for clear-cell renal cell carcinoma detection and biomarker discovery. Journal of Proteomics 2020;215:103671. [DOI: 10.1016/j.jprot.2020.103671] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
2 Oros D, Ceprnja M, Zucko J, Cindric M, Hozic A, Skrlin J, Barisic K, Melvan E, Uroic K, Kos B, Starcevic A. Identification of pathogens from native urine samples by MALDI-TOF/TOF tandem mass spectrometry. Clin Proteomics 2020;17:25. [PMID: 32581661 DOI: 10.1186/s12014-020-09289-4] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
3 Clark DJ, Zhang H. Proteomic approaches for characterizing renal cell carcinoma. Clin Proteomics 2020;17:28. [PMID: 32742246 DOI: 10.1186/s12014-020-09291-w] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
4 Na Nakorn P, Pannengpetch S, Isarankura-Na-Ayudhya P, Thippakorn C, Lawung R, Sathirapongsasuti N, Kitiyakara C, Sritara P, Vathesatogkit P, Isarankura-Na-Ayudhya C. Roles of kininogen-1, basement membrane specific heparan sulfate proteoglycan core protein, and roundabout homolog 4 as potential urinary protein biomarkers in diabetic nephropathy. EXCLI J 2020;19:872-91. [PMID: 32665774 DOI: 10.17179/excli2020-1396] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
5 Wu Q, Fenton RA. Urinary proteomics for kidney dysfunction: insights and trends. Expert Rev Proteomics 2021;18:437-52. [PMID: 34187288 DOI: 10.1080/14789450.2021.1950535] [Reference Citation Analysis]
6 Huang P, Kong Q, Gao W, Chu B, Li H, Mao Y, Cai Z, Xu R, Tian R. Spatial proteome profiling by immunohistochemistry-based laser capture microdissection and data-independent acquisition proteomics. Anal Chim Acta 2020;1127:140-8. [PMID: 32800117 DOI: 10.1016/j.aca.2020.06.049] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
7 Xiao Q, Zhang F, Xu L, Yue L, Kon OL, Zhu Y, Guo T. High-throughput proteomics and AI for cancer biomarker discovery. Adv Drug Deliv Rev 2021;:113844. [PMID: 34182017 DOI: 10.1016/j.addr.2021.113844] [Reference Citation Analysis]
8 Tang X, Xiao X, Sun H, Zheng S, Xiao X, Guo Z, Liu X, Sun W. 96DRA-urine: A high throughput sample preparation method for urinary proteome analysis. J Proteomics 2022;:104529. [PMID: 35181559 DOI: 10.1016/j.jprot.2022.104529] [Reference Citation Analysis]
9 Shao D, Huang L, Wang Y, Cui X, Li Y, Wang Y, Ma Q, Du W, Cui J. HBFP: a new repository for human body fluid proteome. Database (Oxford) 2021;2021:baab065. [PMID: 34642750 DOI: 10.1093/database/baab065] [Reference Citation Analysis]
10 Li W, Yan D, Jin Y, Li H, Ma M, Wu Z. Application of Mass Spectrometry in Analysis of Non-Enzymatic Glycation Proteins in Diabetic Blood. Chinese Journal of Analytical Chemistry 2019;47:1732-41. [DOI: 10.1016/s1872-2040(19)61197-7] [Reference Citation Analysis]
11 Huang L, Shao D, Wang Y, Cui X, Li Y, Chen Q, Cui J. Human body-fluid proteome: quantitative profiling and computational prediction. Brief Bioinform 2021;22:315-33. [PMID: 32020158 DOI: 10.1093/bib/bbz160] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
12 Dayon L, Cominetti O, Affolter M. Proteomics of Human Biological Fluids for Biomarker Discoveries: Technical Advances and Recent Applications. Expert Rev Proteomics 2022. [PMID: 35466824 DOI: 10.1080/14789450.2022.2070477] [Reference Citation Analysis]
13 Zhao L, Zhang Y, Liu F, Yang H, Zhong Y, Wang Y, Li S, Su Q, Tang L, Bai L, Ren H, Zou Y, Wang S, Zheng S, Xu H, Li L, Zhang J, Chai Z, Cooper ME, Tong N. Urinary complement proteins and risk of end-stage renal disease: quantitative urinary proteomics in patients with type 2 diabetes and biopsy-proven diabetic nephropathy. J Endocrinol Invest 2021. [PMID: 34043214 DOI: 10.1007/s40618-021-01596-3] [Reference Citation Analysis]